E-LIB Suche - Ergebnisse für: Jiang Hudachuan

1

The 6-Month Antibody Durability of Heterologous Convidecia ..:

Jiang, Hudachuan ; Jin, Pengfei ; Guo, Xiling...
Vaccines. 11 (2023) 12 - p. 1815 , 2023

Link: https://doi.org/10.3390/..

2

Safety and Immunogenicity of Homologous Recombinant Adenovi..:

Jia, Siyue ; Zhang, Jinlong ; Wang, Xue...
Infectious Diseases and Therapy. 12 (2023) 12 - p. 2757-2769 , 2023

Link: https://doi.org/10.1007/..

3

Safety and Immunogenicity of Homologous Recombinant Adenovi..:

Jia, Siyue ; Zhang, Jinlong ; Wang, Xue...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746682/. , 2023

Link: http://www.ncbi.nlm.nih...

4

The 6-Month Antibody Durability of Heterologous Convidecia ..:

Hudachuan Jiang ; Pengfei Jin ; Xiling Guo...
https://www.mdpi.com/2076-393X/11/12/1815. , 2023

Link: https://doi.org/10.3390/..

5

Safety and Immunogenicity of Homologous Recombinant Adenovi..:

Siyue Jia ; Jinlong Zhang ; Xue Wang...
https://doi.org/10.1007/s40121-023-00892-0. , 2023

Link: https://doi.org/10.1007/..

6

The 6-Month Antibody Durability of Heterologous Convidecia ..:

Jiang, Hudachuan ; Jin, Pengfei ; Guo, Xiling...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747853/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Head-to-head comparisons of the neutralizing antibody again..:

Jiang, Hu-Dachuan ; Guo, Xi-ling ; Jin, Peng-Fei...
Emerging Microbes & Infections. 11 (2022) 1 - p. 1751-1753 , 2022

Link: https://doi.org/10.1080/..

8

A comparison of the test-negative and the matched case-cont..:

Zhang, Li ; Jin, Pengfei ; Wei, Mingwei...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

9

A comparison of the test-negative and the matched case-cont..:

Li Zhang ; Pengfei Jin ; Mingwei Wei...
http://dx.doi.org/10.1080/21645515.2022.2073751. , 2022

Link: https://doi.org/10.1080/..

10

Head-to-head comparisons of the neutralizing antibody again..:

Hu-Dachuan Jiang ; Xi-ling Guo ; Peng-Fei Jin...
https://www.tandfonline.com/doi/10.1080/22221751.2022.2095931. , 2022

Link: https://doi.org/10.1080/..

11

Challenges of COVID-19 vaccination in patients with cancer:

Jia Siyue ; Zhu Wenbo ; Jiang Hudachuan.
https://www.sciengine.com/doi/10.1360/nso/20220004. , 2022

Link: https://doi.org/10.1360/..

12

The COVID-19 Vaccine in Clinical Trials: Where Are We Now?:

Jiang, Hu-Dachuan ; Li, Jing-Xin ; Zhang, Peng..
Infectious Diseases & Immunity. 1 (2021) 1 - p. 43-51 , 2021

Link: https://doi.org/10.1097/..

13

Next Steps for Efficacy Evaluation in Clinical Trials of CO..:

Jiang, Hu-Dachuan ; Zhang, Li ; Li, Jing-Xin.
Engineering. 7 (2021) 7 - p. 903-907 , 2021

Link: https://doi.org/10.1016/..

14

Coronavirus disease 2019 vaccines: landscape of global stud..:

Jiang, Hu-Da-Chuan ; Tao, Yan-Yang ; Jia, Si-Yue..
Chinese Medical Journal. 134 (2021) 17 - p. 2037-2044 , 2021

Link: https://doi.org/10.1097/..

15

Coronavirus disease 2019 vaccines: landscape of global stud..:

Hu-Da-Chuan Jiang ; Yan-Yang Tao ; Si-Yue Jia...
http://journals.lww.com/10.1097/CM9.0000000000001688. , 2021

Link: https://doi.org/10.1097/..